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Abstract: 18
Plasma membrane proteins involved in transport processes play a crucial role in cell 19
physiology. On account of these properties, these molecules are ideal targets for 20
development of new therapeutic and agronomic agents. However, these proteins are 21
of low abundance, which limits their study. Although yeast seems ideal for expressing 22
heterologous transporters, plasma membrane proteins are often retained in 23
intracellular compartments. We tried to find yeast mutants potentially able to improve 24
functional expression of a whole set of heterologous transporters. We focused on 25
Arabidopsis thaliana ureide transporter 1 (AtUPS1), previously cloned by functional 26
complementation in yeast. Tagged versions of AtUPS1 remain mostly trapped in the 27
endoplasmic reticulum and were able to reach slowly the plasma membrane. In 28
contrast, untagged AtUPS1 is rapidly delivered to plasma membrane, where it 29
remains in stable form. Tagged and untagged versions of AtUPS1 were expressed in 30
cells deficient in the ubiquitin ligase Rsp5p, involved in various stages of the 31
intracellular trafficking of membrane-bound proteins. rsp5 mutants displayed further 32
plasma membrane stabilization of untagged AtUPS1, and improved steady state 33
amounts of tagged versions of AtUPS1. rsp5 cells are thus powerful tools to solve the 34
many problems inherent in heterologous expression of membrane proteins in yeast, 35
including ER retention.36
37
38
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Introduction: 38
39
Systematic sequencing of the genomes of complex organisms (e.g., the plant 40
Arabodopsis thaliana, certain parasites, and man) has revealed a great number of 41
genes that are likely to code for membrane transporters [1]. Many of these proteins 42
are assigned to this functional category on the sole basis of sequence similarity to 43
known transport proteins. Their biochemical properties are thus unknown and 44
information regarding substrate specificity is often lacking. To possess such 45
knowledge would be important both scientifically and industrially, because transport 46
proteins (channels, pumps, and carriers) play a crucial role in cell physiology. This is 47
illustrated by the numerous genetic diseases that are caused by defective transport 48
systems. Furthermore, cell surface membrane transporters may be ideal targets for 49
the development of new therapeutic or agronomic agents. Biological systems are 50
thus required for the functional expression of each transport protein and for the study 51
of its biochemical properties by means of quick, simple tests. The yeast 52
Saccharomyces cerevisiae expression system best meets these requirements. It is 53
easy to use and inexpensive, its "transportome" has been extensively analyzed in 54
silico  [2,3] and the function of over 150 yeast transport proteins has been identified 55
[4]. Moreover, the construction of a complete collection of strains deleted for each of 56
the 6200 yeast genes [5] led to an impressive number of S. cerevisiae mutants 57
deficient in the transport of compounds as diverse as inorganic ions, metabolites, and 58
drugs. The phenotypes of these mutants are easily identified after growth on solid 59
media and have been used extensively in complementation tests, notably to clone 60
and characterize heterologous transporters. 61
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 Hundreds of plant transporters have been successfully cloned by 62
complementation in yeast [6-9].The yeast system has also been used in biochemical 63
approaches, for example, to analyze the functional properties of plant H+-ATPases 64
[10]. Nevertheless, although yeast seems ideal for expressing plasma membrane 65
proteins including transporters and receptors, investigators often found some of 66
these proteins to be inactive in yeast, sometimes because the protein did not fold 67
properly and/or was not delivered to the plasma membrane but accumulated in a 68
secretory compartment (endoplasmic reticulum (ER), Golgi apparatus, secretory 69
vesicles), sometimes even leading to formation of karmellae [11]. On the other hand, 70
some heterologous proteins correctly delivered to the plasma membrane have been 71
described to undergo rapid endocytosis and turnover, resulting in low plasma 72
membrane levels [12].73
A few attempts to improve functional expression in yeast of heterologous 74
plasma membrane transporters have been reported, but they often focused on only 75
one given transporter [13,14]. Attempts to identify yeast mutants that would 76
potentially improve the functional expression of a whole set of plasma membrane 77
proteins and more specifically transporters, are still lacking. Finding such mutants for 78
improvement of the functional expression of several plant and mammalian 79
transporters was the objective of an European network, EFFEXPORT (“Engineering 80
yeast for efficient expression of heterologous membrane transporters"). We report 81
here  data we obtained within EFFEXPORT in the case of the Arabidopsis Thaliana82
ureide transporter (AtUPS1), already known to be functionally expressed in S. 83
cerevisiae [15]. AtUPS1, was identified by functional complementation of a yeast dal4 84
dal5 mutant [15] defective in uptake of allantoin. AtUPS1 belongs to a superfamily of 85
plant transporters with five members in Arabidopsis. Analysis of hydrophobicity 86
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predicts 10 putative transmembrane domains, with N- and C-termini predicted to 87
protrude into the extracellular space. UPS proteins display a conserved central 88
domain between predicted transmembrane helices 5 and 6, which contains a 89
consensus sequence for a P loop, also designated as a « Walker A » motif for ATP 90
binding [15]. Expression in yeast and Xenopus oocytes allowed to demonstrate that 91
AtUPS1 mediates uptake of allantoin and related metabolites including uracil [15,16]. 92
The fate of AtUPS1 can thus be compared to that of the endogenous uracil 93
permease (Fur4p), a well-known yeast transporter, the trafficking of which has been 94
studied extensively (reviewed in [17]). Fur4p, which belongs to a family of five 95
homologous proteins in S. cerevisiae [2], also consists of ten transmembrane spans, 96
with cytoplasmic oriented N- and C- termini [18]. Like most yeast plasma membrane 97
proteins, it displays plasma membrane ubiquitylation, catalyzed by the Rsp5p 98
ubiquitin protein ligase, a modification triggering its internalization and subsequent 99
vacuolar degradation [19]. The same ubiquitin ligase, the sole member of the family 100
of Nedd4 ubiquitin ligases in yeast [20], was also demonstrated to be required for 101
direct Golgi-to-vacuole trafficking of a number of plasma membrane transporters, 102
including Fur4p [17,21], i.e. proteins routed to a direct degradation pathway 103
bypassing the plasma membrane under certain nutrient/substrate conditions. Rsp5p 104
was also described to be required for Golgi-to-vacuole traffic of misfolded plasma 105
membrane proteins misrouted to the vacuole [22]. In latter two cases, these proteins 106
were retargeted to plasma membrane in rsp5 mutants. rsp5 mutants thus display 107
increased steady state amounts of many plasma membrane transporters (reviewed 108
in [17]), and were good candidates for potential improvement of functional expression 109
of heterologous transporters. However, in addition to its role in trafficking of 110
membrane proteins [17], Rsp5p has many other functions, including essential 111
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functions [23,24]. Hence, only defined rsp5 mutants may be used for optimization of 112
functional expression of heterologous proteins. Two viable rsp5 mutants that were 113
described to be affected for several of the trafficking functions of Rsp5p appeared 114
interesting: npi1 mutant, with altered RSP5 promoter, leading to a 10-fold reduction in 115
the steady state amount of this protein [25], and rsp5C2, lacking Rsp5p C2 domain 116
involved in localization of the enzyme at plasma membrane and endosomes [26]. 117
We report here an analysis of the fate of AtUPS1, as compared to that of 118
Fur4p, in wild type and rsp5 mutant cells, and show that npi1 and rsp5C2 cells 119
improved functional expression of the plant transporter.120
121
Results122
123
AtUPS1 mediates high affinity uracil transport in yeast124
As outlined above, when expressed in y ast, AtUPS1 transports [14C] labelled 125
allantoin with high affinity and potentially other heterocyclic compounds as suggested 126
by competition studies [15]. Moreover, AtUPS1 m diates uracil uptake  when 127
expressed in Xenopus oocytes [16]. In order to monitor the intracellular fate of 128
AtUPS1 in yeast, UPS1 was cloned in a multicopy plasmid under the control of the 129
galactose-inducible GAL promoter. We defined the characteristics of uracil uptake 130
mediated by GAL-UPS1, as compared to uracil uptake mediated by the endogenous 131
Fur4p cloned under the control of the same promoter. fur4 cells grown on galactose 132
expressing either GAL-UPS1 or GAL-FUR4 displayed high sensitivity to 5-fluorouracil 133
(5FU), a toxic analog of uracil: cells expressing the transporters were unable to grow 134
on plates containing 1µM 5FU, whereas cells transformed with a control plasmid 135
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7
grew normally (Fig 1A). To determine the uracil transport properties of AtUPS1 136
quantitatively, radiotracer uptake studies were performed using [14C] uracil. [14C] 137
uracil uptake mediated by GAL-UPS1 expressed in fur4 cells growing exponentially 138
and fully induced on galactose was linear for at least 3 min, concentration-139
dependent, and displayed saturation kinetics with an apparent Km of 6 µM, close to 140
that observed in parallel for cells expressing GAL-FUR4 (7.5 µM). fur4 cells 141
expressing GAL-UPS1 grown overnight in galactose containing media displayed an 142
activity 50% of cells expressing GAL-FUR4, i.e., more than 30-fold that of 143
chromosomal encoded FUR4 (Fig. 1B), thus providing a sensitive assay to follow 144
AtUPS1 intracellular fate.145
146
Insight into AtUPS1 intracellular trafficking in yeast147
Inducibility of AtUPS1 synthesis after galactose induction provides a useful 148
tool for monitoring plasma membrane delivery, as previously demonstrated for the 149
yeast Fur4p [27]. We measured uracil uptake activity after galactose induction of 150
GAL-UPS1 and GAL-FUR4 in fur4 cells in parallel (Fig. 2A). In both cases, activity, 151
as a measure of plasma membrane targeting, was detectable after 30 min induction. 152
The increase in uracil uptake activity was linear for one hour with a similar slope for 153
cells expressing the yeast and the plant transporters. Hence the heterologous 154
AtUPS1 appears to be recognized efficiently by the yeast secretory machinery. We 155
then compared the fate of AtUPS1 and Fur4p along the endocytic pathway using an 156
experimental condition known to trigger rapid Fur4p internalization and subsequent 157
vacuolar degradation, i. e. the inhibition of protein synthesis by addition of 158
cycloheximide [28] (Fig. 2B). Cycloheximide was added to exponentially growing 159
fur4 cells induced overnight in galactose for expression of either AtUPS1 or Fur4p. 160
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8
Uracil uptake activity of cells expressing Fur4p decreased rapidly (t 1/2= 45 min), 161
whereas uracil uptake activity of cells expressing AtUPS1 did not display a decrease 162
for four hours. Hence, once delivered to the plasma membrane, the plant AtUPS1 163
was remarkably stable, and did not undergo obvious endocytosis after inhibition of 164
protein synthesis.165
166
C-terminally tagged versions of AtUPS1 are retained in the ER167
The monitoring of uracil uptake activity can afford insight into the intracellular 168
fate of AtUPS1, since it provides information about the plasma membrane located 169
transporter. This information, however, remains limited, and does not indicate the 170
fraction of plasma membrane-delivered protein versus potential intracellular pools. In 171
the absence of available antibodies, we decided to monitor the fate of tagged 172
versions of AtUPS1. C-terminally tagged versions of AtUPS1 were constructed, first 173
with a GFP-tag, a powerful tool for monitoring the intracellular fate in yeast of plasma 174
membrane proteins of heterologous [14] or endogenous origin, including that of 175
Fur4p [29-31]. fur4 cells transformed with a multicopy plasmid carrying GAL-UPS1-176
GFP displayed high 5FU sensitivity after growth on galactose (Fig. 3A). Strikingly, 177
fur4 cells transformed with multicopy plasmid carrying GAL-UPS1 tagged with the 178
smaller HA epitope displayed intermediate 5FU sensitivity after growth on galactose, 179
indicating that a smaller tag did not improve AtUPS1 functionality. According to these 180
plate assays, C-terminally tagged AtUPS1 thus appeared functional, notably GFP-181
tagged AtUPS1. However, fur4 cells transformed by the multicopy plasmid carrying 182
GAL-UPS1-GFP and fully induced displayed only a very low level of uracil uptake 183
activity (0.04 nMol/min/A600), an activity 50 fold lower than that observed in the case 184
of induced cells transformed by a plasmid carrying untagged AtUPS1 (not shown). 185
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The use of a smaller tag (HA) or another promoter (CYC1) did not improve uracil 186
uptake activity.187
The GFP -or HA- tags may inhibit transport activity or impair plasma 188
membrane delivery of tagged transporter due to folding problems. We checked GFP 189
fluorescence in time course experiments using the multicopy plasmid carrying the 190
GAL-UPS1-GFP (Fig. 3B), or the multicopy plasmid GAL-Fur4-GFP as a control. 191
Galactose induction of Fur4-GFP led, after 30 min, to observation of small internal 192
compartments, likely Golgi/secretory vesicles. 30 min later, plasma membrane 193
staining was clearly evidenced, often in a polarized fashion, with intense staining of 194
small buds (Fig. 3B). The distribution of AtUPS1-GFP was strikingly different. After 195
30 min of galactose induction of AtUPS1-GFP expression, a perinuclear staining was 196
clearly observable. 30 min later, or after overnight induction, the perinuclear staining 197
was still present and a discontinuous staining at/or underneath the plasma 198
membrane has appeared. This pattern is typical of the yeast ER. Intense staining of 199
lines or spots, as if intracellular membranes had formed aggregates were also 200
visualized (Fig. 3B). Indeed, electron microscopy of the ultrastructural morphology of 201
cells fully induced for expression of AtUPS1-GFP revealed proliferation, hanks of ER 202
membranes (Fig. 3D), as often described in the case of cells overexpressing ER-203
retained proteins [11]. This altered morphology did not resulted from the 204
overexpression of a membrane protein as such: overnight overexpression of 205
endogenous FUR4 from the same multicopy, GAL-inducible plasmid, did not lead to 206
altered morphology (not shown).   207
ER-retention of GFP-tagged AtUPS1 apparently did not result from the mere 208
overexpression of this protein. Perinuclear/ER staining was also evidenced upon 209
expression of AtUPS1-GFP from a centromeric plasmid under the control of the mild 210
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strength CYC1 promoter, leading to a steady state protein level about 4-fold lower 211
than that observed after two hours galactose induction of GAL-UPS1-GFP (Fig. 3B 212
and C). Furthermore, when analyzed by sucrose gradient fractionation, AtUPS1-GFP 213
expressed from the CEN CYC1-plasmid or from the 2 µ GAL-inducible plasmid 214
displayed exactly the same pattern with major pool in internal fractions (data not 215
shown). 216
Hence, the GFP tag at the C-terminus of AtUPS1 obviously triggers ER 217
retention of the transporter. The low uracil uptake activity of cells expressing this 218
transporter can only be observed after long expression periods (3-4 hours, cf Fig. 219
6B), and likely corresponds to the low fraction of protein finally reaching the plasma 220
membrane. With such folding problems, overexpression is a way to increase steady 221
state plasma membrane expression: both 5FU sensitivity and uracil uptake activity 222
were improved in the case of AtUPS1-GFP expression from a multicopy plasmid and 223
strong GAL promoter compared to expression from a centromeric plasmid under the 224
control of a lower strength promoter.225
226
Intracellular fate of AtUPS1 carrying an internal myc tag in yeast: slow ER exit 227
but final plasma membrane delivery 228
We checked whether insertion of a small myc-tag inside the central loop 229
containing the Walker A motif would be a better way to study AtUPS1 intracellular 230
trafficking. Cells expressing internally myc tagged AtUPS1 from a multicopy 231
galactose inducible plasmid displayed high sensitivity to 5FU (Fig. 4A). Cells 232
transformed with the multicopy GAL-UPS1myc plasmid grown overnight in galactose 233
displayed a relatively high level of uracil uptake activity: 1 nMol/min/A600, i. e. 70% 234
that observed in the case of untagged AtUPS1 (Fig. 4B), suggesting that the myc tag 235
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at this position had only a small impact on AtUPS1 function. However, this tag had a 236
clear influence on AtUPS1 intracellular trafficking. Induction experiments showed that 237
uracil uptake activity appeared slowly: 4-6 hours were necessary before we were 238
able to measure any detectable uptake activity (Fig. 4C). Aliquots withdrawn at 239
several time points after galactose induction were analyzed by protein gel blots using 240
a specific anti-myc antibody. AtUPS1myc appeared on gels as a band of apparent 241
molecular mass of about 36 kDa, i. e. slightly below the expected molecular mass 242
deduced from predicted protein sequence (44 kDa) (Fig. 4E), as often observed for 243
very hydrophobic proteins. A comparable pattern was observed after overnight 244
galactose induction of AtUPS1myc expressed from either a centromeric or a multicopy 245
plasmid (data not shown). 246
In order to check the intracellular location of AtUPS1myc derived species, cells 247
transformed with GAL-UPS1myc were induced by addition of galactose, aliquots 248
withdrawn periodically were fixed and analyzed by immunofluorescence using a 249
monoclonal anti-myc antibody. One hour induction was sufficient to observe a 250
specific signal, mostly perinuclear, supported by simultaneous DAPI staining (Fig. 251
5A). To obtain better resolution of the cell surface staining (potentially corresponding 252
to either ER or plasma membrane), cells were examined by confocal microscopy. 253
The lower background in optical slices made it possible to show that all cells 254
displayed perinuclear staining, together with discontinuous regions of cell surface 255
staining (Fig. 5B). Because cell surface was not homogeneously stained, we can 256
conclude that the main signal corresponds to ER staining and that a plasma 257
membrane localisation cannot be detected by this approach. The low rate of uracil 258
uptake activity thus likely resulted from low ER exit rates (Fig. 4C) The finding that 259
the activity of fully induced cells is in a similar range as that of cells expressing 260
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untagged AtUPS1, which was rapidly targeted to plasma membrane, may suggest 261
that after slow rates of ER exit, AtUPS1myc finally reached the plasma membrane. 262
Further indication that AtUPS1myc stored in internal compartments could finally reach 263
plasma membrane was provided by the observation of some increase in uracil 264
uptake activity after stopping transporter synthesis by the addition of CHX (Fig. 4D).   265
Once targeted at the plasma membrane, AtUPS1myc was rather stable, as judged 266
from the extreme stability of uracil uptake activity for over 3 hours after this transient 267
uracil uptake activity increase following CHX addition. However, some low rate 268
endocytosis likely occurred as compared to the incredibly stable untagged AtUPS1 269
(Fig. 4D).270
271
272
Mutations in the Rsp5 ubiquitin protein ligase improve functional expression of 273
tagged and untagged AtUPS1 in yeast 274
Despite the difficulties encountered in tagging AtUPS1 at different positions, 275
the high sensitivity of the two functional tests, 5FU sensitivity and uracil uptake 276
measurements, provided suitable tools to check whether yeast mutants could 277
improve the steady state levels of functional tagged or untagged AtUPS1 versions. 278
We used two viable rsp5 mutants, npi1 and rsp5C2, that display delayed 279
endocytosis of several cargoes, including Fur4p. Accordingly, they displayed 280
increased 5FU sensitivity as a result of the plasma membrane stabilization of 281
endogenous chromosomal or plasmid encoded Fur4p (not shown). We checked the282
fate of tagged and untagged versions of AtUPS1 in npi1 and rsp5C2 mutant cells.283
For this purpose, FUR4 was deleted in wild type, npi1 and rsp5C2 cells, and 284
the resulting strains were transformed with multicopy plasmids carrying either UPS1 285
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under the control of the constitutive PGK promoter (plasmid pFL61-UPS1), or 286
galactose inducible UPS1, UPS1-GFP and UPS1myc. Transformed cells grown in 287
glucose, or galactose containing media in the case of plasmids with a GAL promoter 288
displayed identical growth in the absence of 5FU (Fig. 6A), indicating that neither the 289
mutations, nor the expression of the plant transporters impaired growth. 5FU 290
sensitivity of transformants was strikingly enhanced in both rsp5C2 and npi1 cells 291
expressing the tagged and untagged plant transporter when compared to wild type 292
cells, with slightly stronger effect promoted in all cases by the npi1 mutation  293
(compare the size of isolated colonies) (Fig. 6A). This suggests higher amounts of 294
plasma membrane tagged or untagged transporters in the mutants. In the case of the 295
untagged transporters, the enhancement in 5FU sensitivity was evidenced after 296
synthesis from PGK or GAL10 promoter at different 5FU concentrations (Fig. 6A), 297
indicating that rsp5 mutations interfered with trafficking, rather than with galactose-298
driven expression. For untagged AtUPS1 which is rapidly delivered to the plasma 299
membrane and very stable in wild type cells, the increase in functional transporter 300
activity observed in rsp5 mutants may result from inhibition of some direct Golgi to 301
vacuole targeting, or from protection against a possible low basal endocytosis, for 302
instance when cells reached stationary phase, a likely situation for cells grown 303
several days on plates.304
In the case of the myc-tagged version of AtUPS1, we monitored the fate of the 305
transporter after galactose induction by western blots (Fig 6C), and uracil uptake 306
measurements (Fig. 6B). In agreement with fluorescent data, AtUPS1myc protein was 307
already detectable in wild type cells at early time points after induction (30-60 min) 308
but uracil uptake was readily measurable only at far later time points (4 hours). In 309
npi1 cells, AtUPS1myc was detectable in higher amounts at all time points and uracil 310
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uptake activity appeared at least one hour earlier compared to wild type cells (Fig. 311
6B). rsp5C2 mutation also resulted in more rapid appearance of uracil uptake 312
activity. Strikingly, even if the activity was lower for cells expressing AtUPS1-GFP 313
compared to AtUPS1myc, the rate of appearance of uptake was very similar. For both 314
types of tagged transporters uracil uptake activity was thus 2-3 fold higher in mutant 315
cells than in wild type cells after 4 hour induction. Since the major pool of both 316
AtUPS1-GFP and AtUPS1myc seemed to be in the ER, both npi1 and rsp5C2 317
mutations apparently lead to accelerated ER exit. 318
319
Discussion:320
The use of a regulable promoter and the high sensitivity of uracil uptake 321
measurements enabled us to obtain crucial information about the fate of untagged 322
AtUPS1 uracil transporter in yeast. AtUPS1 is rapidly delivered to the plasma 323
membrane, with kinetics indistinguishable from those of endogenous yeast 324
transporter. Hence, the yeast secretory pathway efficiently handles the heterologous 325
plant transporter. It is possible that such property was the reason for the successful 326
cloning by functional expression of so many plant transporters when using yeast as a 327
host system [6,7]. Plasma membrane delivered AtUPS1 exhibited striking stability, 328
notably when compared to the endogenous yeast uracil permease especially 329
susceptible to stress-induced endocytosis [28]. This was true for both untagged 330
transporter and for internally tagged AtUPS1myc (not shown). This differential stability 331
between yeast and plant uracil transporters may possibly reflect fundamental 332
differences in their endocytic processes. Endocytosis in yeast is dependent on prior 333
ubiquitylation of plasma membrane cargoes by the Rsp5p ubiquitin protein ligase 334
[17]. A subset of mammalian proteins undergo ubiquitin-dependent endocytosis, 335
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sometimes involving ubiquitin-protein ligases of the Nedd4/Rsp5 family [32]. In 336
contrast, although plants display numerous ubiquitin protein ligases, they do not 337
seem to have Rsp5p orthologs [33]. The extreme stability of AtUPS1 in yeast could 338
result from the absence or low accessibility of ubiquitylation sites that Rsp5p can 339
recognize, at least under the experimental conditions we tested. One possible reason 340
could be the lumenal orientation of both AtUPS1 N- and C-termini.341
In addition to obtaining information on intracellular trafficking of the plant 342
AtUPS1 in yeast based on uptake measurements, we tried to gain new insights into 343
the biochemical properties of this transporter. Unfortunately, tagging the transporter, 344
either at the N-terminus (not shown) and C-terminus or inside its central loop, lead to345
folding problems, often resulting in ER retention of most of the protein, preventing us 346
from using these tagged versions to obtain a judicious biochemical characterization 347
of this transporter. A marked difference, however, was observed between internal 348
tagging, and tagging at the N- and C-termini, which was far more deleterious. 349
Internally tagged transporter displayed delayed ER exit, but finally reached the 350
plasma membrane in a fully functional state, and fully induced cells expressing this 351
version of the transporter displayed activity clos ly resembling that of cells 352
expressing untagged transporter. In contrast, cells expressing C-terminally tagged 353
transporter displayed 40-fold less uracil uptake activity compared to cells expressing 354
untagged transporters, probably because of a very low percentage of the protein355
exiting the ER.  In latter case, some improvement could be achieved by increased 356
levels of expression (stronger promoter, multicopy versus centromeric plasmid). The 357
deleterious effect of C-terminal tags could result from the unusual structure of the 358
transporter. Hydrophobicity plot analysis of proteins of the UPS family suggested an 359
external orientation of both termini [15] a situation somewhat rare for transporters. 360
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Most yeast transporters, for instance, display cytoplasmic oriented termini, as 361
predicted from hydrophobicity plot analysis or from experimental data [2]. Many of 362
these tranporters were studied after tagging, most often at their C-terminus, a 363
modification that did not induce any major trafficking problems. The observation that 364
N- and C-terminal tags impaired AtUPS1 folding is compatible with an external 365
orientation, but experimental data are required to prove this. One obvious lesson 366
from these observations is that tagging at the positions and with the tags used in the 367
present study may probably influence the fate of UPS proteins in plant cells in a 368
similar way as in yeast cells. Indeed, previous studies attempting to study the 369
subcellular location of N- or C-terminal fusions of UPS proteins with GFP by transient 370
expression in Arabidopsis protoplasts showed that these fusion proteins did not 371
reach the plasma membrane (Schmidt, A., Baumann, N. and Desimone, M., 372
unpublished data). This suggests that yeast may also represent a useful 373
experimental system to decipher where tags can be introduced in heterologous 374
transporters.375
The distinctive behaviour of the various versions of AtUPS1, one correctly 376
targeted to the plasma membrane, and two retained in the ER to various extents, 377
provided the opportunity to check how to improve the steady state plasma membrane 378
amount of heterologous transporters with distinct intracellular fates. We checked 379
specifically the influence of mutations in Rsp5p. This ubiquitin protein ligase is 380
involved in various stages of intracellular trafficking of membrane-bound proteins, 381
including ER-associated degradation, plasma membrane internalization, Golgi to 382
vacuolar trafficking, and sorting to multivesicular bodies [17]. Limiting or preventing 383
latter three trafficking steps results in elevated steady state levels of yeast 384
transporters. Two specific viable mutants were used, npi1, with decreased amounts 385
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of Rsp5p [25] and rsp5C2, lacking the C2 domain of Rsp5p [34], dispensable for 386
viability, but critical for Rsp5p trafficking functions [26,34-38]. Strikingly, both mutants 387
improved steady state amounts of functional, plasma membrane targeted, tagged 388
and untagged versions of AtUPS1, as judged from increased 5FU sensitivity. In the 389
case of untagged transporter, increased 5FU sensitivity was observed after 390
expression of the transporter under the control of the constitutive PGK promoter, or 391
the inducible GAL10 promoter, indicating that the mutations interfered as expected 392
with trafficking rather than with expression. 393
In the case of the untagged version of AtUPS1, it was difficult to further 394
explore the mechanism of this improvement. Plasma membrane AtUPS1 was so 395
stable in wild type cells submitted to CHX treatment that further stabilisation in rsp5396
cells could not be detected in this type of experiment. The improvement in plasma 397
membrane steady state amounts of AtUPS1 in npi1 and rsp5C2 cells might possibly 398
arise from a low basal endocytosis of AtUPS1, undetectable in CHX chase 399
experiments, but possibly occurring once cells reach stationary phase, as is the case 400
for cells grown on plates. Alternatively, the increase in plasma membrane AtUPS1 in 401
these rsp5 mutants could result from a decreased direct Golgi to vacuole targeting of 402
a fraction of the transporter.403
Mutations in RSP5, either npi1 or rsp5C2, had a similar impact on the 404
intracellular fate of tagged versions of AtUPS1 at both the C-terminus or in the 405
intracellular loop. These two variants of AtUPS1 were mainly located in the ER, with 406
possibly exit in only very limited amounts (AtUPS1-GFP), or more important final 407
amounts (AtUPS1myc) thus leading to uracil uptake activity similar to that displayed by 408
cells expressing untagged transporters.  In both cases, the rate of plasma membrane 409
delivery of uracil uptake activity was greatly delayed, with activity measurable after 3-410
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4 hours induction instead of 30 min for AtUPS1 –i. e. long after detection of the 411
protein on Western blots- and the two rsp5 mutations reduced this delay. At first 412
glance, this effect can be attributed to an effect of Rsp5p on ER exit. Among its many 413
functions, Rsp5p was described to be involved in ubiquitylation followed by 414
proteasome degradation of several misfolded soluble and membrane-bound proteins 415
retained in the ER, notably under conditions of saturation of other ER-associated 416
degradative (ERAD) pathways [39]. Tagged forms of AtUPS1 might be partly 417
susceptible to such an Rsp5p-dependent ER-associated degradation, and inhibition 418
of this degradation in npi1 and rsp5C2 mutants would result in more rapid ER exit of 419
transporters escaping this degradation to some extent. It is also possible that a small 420
number of misfolded tagged transporters undergo ER to Golgi trafficking, followed by 421
Golgi to vacuole sorting. Rsp5p was also shown to be involved in Golgi to vacuole 422
trafficking of some misfolded mutant plasma membrane proteins [22] or of yeast 423
transporters displaying direct vacuolar targeting under specific nutrient conditions 424
[17]. In both cases in rsp5 mutants, these proteins are directed to plasma membrane 425
[22,40]. A small fraction of tagged AtUPS1 could undergo such direct vacuolar 426
trafficking, a process inhibited in rsp5 mutants. In support of a partial direct Golgi to 427
vacuole trafficking of AtUPS1myc, we observed that pep4 mutant cells, deficient for 428
vacuolar protease activities, displayed higher amounts of the 36 kDa AtUPS1myc429
species than wild type cells even after short induction times, as did vps23 mutants, 430
impaired in Golgi to vacuole trafficking (data not shown). The increase in plasma 431
membrane amounts of functional forms of tagged AtUPS1 in rsp5 mutants, attested 432
in exponentially growing cells by increased uracil uptake activity, and on plates by 433
increased 5FU sensitivity might also result from an inhibition of Rsp5p-dependent 434
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processes at three levels: ERAD, Golgi-to-vacuole trafficking and plasma membrane 435
internalization. 436
Rsp5p plays a key role in trafficking of yeast plasma membrane proteins. The 437
present study shows that several viable rsp5 mutants display increased plasma 438
membrane amounts of a plant transporter, rapidly targeted to the plasma membrane. 439
Strikingly, within the same european network (EFFEXPORT), other laboratories 440
observed, in viable rsp5 mutants, improved functional expression of several 441
heterologous transporters, including several NH4+ transporters (Rh family) of animal 442
origin (Marini A and André B, personal communication), and increased plasma 443
membrane amounts versus internal fractions of mammalian Na+/H+ antiporters 444
(Flegegova, H, Haguenauer-Tsapis, R and Sychrova, H. Biochem. Biophys. Acta, in 445
press). In addition, these mutants optimize plasma membrane delivery of tagged 446
versions of the plant AtUPS1, stacked in the ER as a result of folding problems. ER 447
retention is one of the major problems encountered in the case of expression of 448
heterologous plasma membrane proteins in yeast. The increase in steady state 449
plasma membrane amounts of heterologous plant and mammalian transporters, 450
upon expression in viable rsp5 mutants, show that these cells could be powerful tools 451
to solve the many problems inherent in heterologous expression of membrane 452
proteins, including ER retention. 453
454
Materials and methods455
456
Yeast strains and growth conditions457
Yeast strains were transformed as described by Gietz et al [41]. Cells were grown at 458
30°C in minimal medium (YNB) containing 0.67% yeast nitrogen base without amino 459
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acids (BD bioscience, NJ, USA), and supplemented with appropriate nutrients. The 460
carbon source was 2% glucose, or 2% galactose plus 0.05% glucose as indicated in 461
the figure legends. Galactose induction was performed on cells grown overnight in 462
2% raffinose plus 0.05% glucose up to an A600nm=0.5. Galactose (2%) was then 463
added to the medium.464
The disruption of FUR4 gene was achieved by ORF replacement with long flanking 465
homology regions to the KanMX4 cassette corresponding to the strategy described 466
by Wach [42].467
468
Growth tests in the presence of 5-fluorouracil469
Cells, prototroph for uracil, were cultured overnight in minimal medium containing 470
glucose and spotted on plates containing minimal medium with galactose to induce 471
expression of FUR4 or UPS1 variants and supplemented with various concentrations 472
of 5FU (Sigma-Aldrich, Lyon, France). The first drop contained 3.104 cells and each 473
subsequent drop was diluted six-fold compared to the prior drop. 474
475
Construction of plasmids476
DNA manipulations, including restriction analysis and ligations, were performed 477
essentially as described by Maniatis et al. [43].478
The control plasmid p195gF-GFP (pRT208) expressing FUR4-GFP under the control 479
of the GAL10 promoter was constructed by cloning a PstI/BamH1 fragment (FUR4-480
GFP) from pFL38gF-GFP [30] into p195gF [28] at the PstI/BamHI site.  481
The pGAL-UPS1 (pRT205) plasmid was constructed by insertion of a BamHI/EcoRI 482
fragment encoding UPS1 (with pFL61-UPS1 as a template [15]) in the BamHI/EcoRI 483
site of pYEF1 [44].484
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To construct the plasmid GAL-UPS1-GFP (pRT206) we first built the pNBT29 485
plasmid, which contains the yeast enhanced GFP under the control of the GAL10 486
promoter on a multicopy plasmid. For this purpose, a BamHI/NotI fragment encoding 487
GFP was obtained by PCR using the pUG35 plasmid as a template [45] and 488
introduced at the BamHI/NotI site of pYEF1 [44]. Then a BamHI/ClaI fragment 489
encoding AtUPS1 was amplified by PCR using pFL61-AtUPS1 [15] as a template,490
and introduced at the BamHI/ClaI site of pNBT29 in frame with the coding sequence 491
of GFP thereby creating a GFP C-terminally tagged version of AtUPS1. To construct 492
the CYC1-UPS1-GFP (pRT207) plasmid we cloned the BamHI/EcoRI fragment 493
containing UPS1-GFP at the BamHI/EcoRI site of the p416-CYC1 plasmid [46] .494
The pGAL-UPS1-HA (pRT204) plasmid was obtained by insertion in the ClaI site of 495
the pYEF2 [44], in frame with the coding sequence of the HA tag, of a fragment 496
encoding UPS1 obtained by restriction of the plasmid GAL-UPS1-GFP.497
To construct the plasmid pGAL-UPS1myc (pRT203) two fragments of UPS1 were 498
amplified separately by PCR using pFL61-UPS1 as a template. One fragment 499
contained at start an EcoRI and an XbaI site, the 5’- portion of the UPS1 coding 500
sequence (from ATG to the position 549) and a BamHI site at the end. The other 501
fragment contained a BamHI site at the start, the coding sequence for the c-myc 502
epitope, the 3’- portion of UPS1 (from position 550 to the stop codon), and an EcoRI 503
and a XhoI site at the end. Both fragments were sequentially cloned in pDR199 [47]504
using the EcoRI/BamHI sites for the first fragment and BamHI/and XhoI for the 505
second. After sequencing, the complete c-myc tagged UPS1 sequence was obtained 506
by restriction and subcloned into the Xba I / Xho I sites of the CEN plasmid p416-507
GAL [46]. Afterwards, the multicopy plasmid pGAL-UPS1myc was obtained by 508
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subcloning a SacI/XhoI fragment of the p416-GAL-UPS1myc into the SacI/XhoI sites 509
of the p426-GAL plasmid [46].510
511
Measurement of uracil uptake. 512
Uracil uptake was measured in exponentially growing cells as previously described. 513
Yeast culture (1 ml) was incubated with 5 µM [14C] uracil (ICN biomedicals Illkirch, 514
France) for 20 sec at 30°C, then quickly filtered through Whatman GF/C filters, which 515
were in turn washed twice with ice-cold water and counted for radioactivity. In the 516
case of low uracil uptake activity, this basic protocol was slightly modified, with the 517
use of two ml samples and incubation for 2 min at 30°C. 518
519
Michaelis-Menten kinetics520
Uracil uptake activities measured at various substrate concentrations were fitted to a 521
hyperbola with SIGMA PLOT 5.0, V5 according to Michaelis-Menten kinetics. 522
523
Yeast cell extracts, SDS-PAGE and Western immunoblotting 524
Total protein extracts were prepared by the NaOH/Trichloroacetic acid (TCA) lysis 525
technique as described in [28]. Proteins were separated by SDS-PAGE on Tricine 526
gels and transferred onto nitrocellulose membranes. The membranes were probed 527
with monoclonal antibodies against GFP (Roche Diagnostics Meylan, France), or 528
myc (9E10 from Roche Diagnostics), or polyclonal antibody against Gas1p (a kind 529
gift from H. Riezman). Primary antibodies were detected using horseradish 530
peroxidase-conjugated anti-rabbit or anti-mouse IgG secondary antibody  (Sigma-531
Aldrich, Lyon, France) revealed by ECL chemiluminescence (Amersham). 532
533
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Immunofluorescence534
Immunofluorescence was performed as described in [48] except that cells were 535
permeabilized with 0.5% Triton X100. The primary antibody was the monoclonal anti-536
Myc (9E10 from Roche Diagnostics, Meylan, France)and the secondary antibody 537
was an FITC-conjugated goat anti–mouse-IgG (Jackson ImmunoResearch 538
Laboratories, Inc., West Grove, PA). For DNA staining, 1 µg/ml Diamin-Phenylindol-539
Dihydrochlorid (DAPI) was used. Samples were viewed under an Olympus 540
microscope BY61 using FITC and DAPI filter sets. Image acquisition was performed 541
using a Spot charge-coupled device camera SPOT4.05 .542
For confocal analysis, cells were imaged using an inverted microscope (Leica, Inc.543
Wetzlar, Germany) and scanning was performed with a True Confocal Scanner LEICA 544
TCS 4D.545
546
Electron microscopy547
Yeast cells were fixed by adding 200 µl of 50% aqueous glutaraldehyde to 10 ml of 548
growth medium for 10 min and then centrifuged at 5000 g for 10 min at 4°C. After 549
fixation with fresh fixatives for 2 h at 4°C, cells wer  washed in 0.1 M cacodylate 550
buffer (pH 7.4) and in water. Subsequently, cells were treated with 1% KMnO4 for 2 h 551
on ice, washed in water and re-suspended in 2% aqueous uranyl acetate for 1 h at 552
4°C. Cells were dehydrated in a graded series of ethanol, infiltrated in a mixture of 553
ethanol and Spurr’s resin and embedded in Spurr’s low viscosity media. Thin 554
sections were cut, stained with lead citrate and examined in a Tecnai 12 electron 555
microscope (Eindhoven, Netherlands).556
557
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TABLE 1.  List of strains558
Strain Background Genotype Source
MF04 1278b MATa ura3 trp1 FUR4::KanMX4 This study
MF05 1278b MATa ura3 trp1 rsp5C2 FUR4::kanMX4 This study
MF06 1278b Mata ura3 trp1 npi1 FUR4::kanMX4 This study
27061b 1278b Mata ura3 trp1 [19]
27064b 1278b Mata ura3 trp1 npi1 [19]
BY4741 BY Mata leu2 met15 ura3 his3 Euroscarf
559
560
TABLE 2. List of plasmids561
Plasmid Characteristics Source
pPGK-UPS1 (PFL61-UPS1) 2µ, URA3 prom. PGK-UPS1 [15]
pGAL (PYeF2) 2µ, URA3, prom. GAL10, Cter HA [44]
pGAL-FUR4 (pFL38gF)
p195gF
p195gF-GFP (pRT208)
pGAL-UPS1-HA (pRT204)
CEN, URA3, prom. GAL10, FUR4
2µ, URA3, prom. GAL10, FUR4
2µ, URA3, prom. GAL10-FUR4-GFP
2µ, URA3, prom. GAL10, UPS1- HA
[30]
[28]
This study
This study
pGAL-UPS1 (pRT205) 2µ, URA3, prom. GAL10, UPS1 This study
pGAL-UPS1-GFP (pRT206)
pCYC1-UPS1-GFP (pRT207)
2µ, URA3, prom. GAL10, UPS1-GFP
CEN, URA3, prom.CYC1, UPS1-
GFP
This study
This study
pGAL-UPS1myc(pRT203) 2µ, URA3, prom. GAL10, UPS1-myc This study
562
Page 24 of 38
Wiley-VCH
Biotechnology Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
25
Figure 1: Comparison of uracil uptake activity of Arabidopsis thaliana UPS1 563
expressed in yeast and endogenous uracil permease Fur4p.564
A: 5-Fluorouracil (5FU) sensitivity. fur4 cells transformed with either pGAL (empty 565
vector), pGAL-UPS1 or pGAL-FUR4 were grown on galactose containing plates 566
supplemented or not with 1µM 5FU (toxic analog of uracil).567
B: Uracil uptake activity of AtUPS1 compared to Fur4p. fur4 strains transformed 568
with pGAL (white), pGAL-UPS1(grey) or pGAL-FUR4 (black) were grown to 569
exponential phase in galactose containing medium and used for measurement of 570
[14C] uracil uptakeas described in Materials and Methods. Results are the average of 571
four measures (two measures in two independent experiments). 572
573
Figure 2: Intracellular trafficking of AtUPS1 in yeast.574
A: fur4 strains transformed with pGAL-UPS1 (triangle) or pGAL-FUR4 (circle) were 575
grown with raffinose as a carbon source. Galactose was then added to induce 576
expression of AtUPS1 and FUR4. The kinetics of plasma membrane delivery of 577
AtUPS1 and Fur4p was determined by quantification of [14C] uracil uptake every 30 578
minutes after galactose induction. Results at each time point are the average of two 579
independent measurements.580
B: fur4 strains transformed with pGAL-UPS1 (triangle) or pGAL-FUR4 (circle) were 581
grown in galactose containing medium. Protein synthesis was inhibited by addition of 582
cycloheximide (CHX) (100µg/ml). Uracil uptake activity was measured at various time 583
points (two measurements) after CHX addition. Results are shown as the percentage 584
of initial activities.585
586
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Figure 3: Expression of C-terminally GFP tagged AtUPS1 promotes ER 587
proliferation in yeast 588
A: fur4 cells transformed with pGAL, pGAL-UPS1-HA, pGAL-UPS1-GFP and 589
pCYC1-UPS1-GFP were tested for growth on plates containing or not 5-fluorouracil 590
(0,75 µM).591
B and C: fur4 cells transformed with pCYC-UPS1-GFP, pGAL-UPS1-GFP or pGAL-592
Fur4-GFP were grown to mid exponential phase either in glucose, or in raffinose 593
containing medium in the case of strains bearing a plasmid with a GAL promoter. 594
Galactose was then added to induce AtUPS1-GFP or Fur4-GFP expression. At the 595
indicated times, after galactose addition or after growth in glucose containing media 596
(in the case of pCYC-UPS1-GFP), cells were observed by fluorescence microscopy 597
(B) and protein extracts were prepared, resolved by SDS PAGE and analysed by 598
Western immunoblotting using an anti-GFP antibody (C)599
D: fur4 cells expressing pGAL and pGAL-UPS1-GFP grown overnight in galactose 600
containing media were processed for electron microscopy. White arrows indicate the 601
endoplasmic reticulum and N the nucleus.602
603
Figure 4: Intracellular fate of myc tagged version of AtUPS1604
A: fur4 cells transformed with pGAL, pGAL-UPS1, and pGAL-UPS1myc were tested 605
for 5-fluorouracil (1µM) sensitivity on plates. 606
B: [14C] uracil uptake activity of fur4 cells transformed with pGAL-FUR4, pGAL-607
UPS1 and pGAL-UPS1myc grown to mid exponential phase on galactose containing 608
medium. Results are the average of two independent measures.609
C: fur4 strains transformed with pGAL-UPS1 (triangle) or pGAL-UPS1myc (square) 610
were grown to mid log phase in raffinose containing medium and galactose was then 611
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added to induce expression of the transporter. The kinetics of plasma membrane 612
delivery of AtUPS1 or Fur4p were determined by quantification of [14C] uracil uptake 613
at various times after galactose induction.614
D: fur4 strains transformed with pGAL-UPS1 (triangle) or pGAL-UPS1myc (square) 615
were grown in galactose containing medium. Uracil uptake activity was measured at 616
different time points after inhibition of protein synthesis by addition of CHX 617
(100µg/ml). Results are shown as the percentage of initial activity.618
E: WT cells transformed with pGAL-UPS1myc were grown to mid log phase in 619
raffinose containing medium. Galactose was then added to induce transporter 620
expression. Protein extracts were prepared at indicated times and proteins were 621
resolved by SDS PAGE and analysed by Western immunoblotting using an anti-myc 622
antibody to detect the transporter and an anti-Gas1p as a loading control. 623
624
Figure 5: Intracellular localization of UPS1myc after galactose induction.625
A: fur4 cells transformed with pGAL-UPS1myc were grown overnight in raffinose 626
containing media. Galactose was added during exponential growth phase. Aliquots 627
were withdrawn at various time points, cells were fixed and processed for 628
immunofluorescence. AtUPS1myc was detected using an anti-myc antibody as 629
described in Materials and Methods. The nuclei were stained using DAPI. 630
Fluorescence was observed under an Olympus microscope.631
(Note that, as it is often the case for multicopy plasmid and galactose induction, only 632
a subset of the cells within the population was stained with the anti-myc antibody)633
B: The same preparations as in (A) were also visualized using confocal microscopy. 634
One section is presented for each time point. 635
636
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Figure 6: Mutations in RSP5 improve functional expression in yeast of tagged 637
and untagged UPS1638
A: fur4, rsp5C2 fur4 and npi1 fur4 cells transformed with pPGK-UPS1, pGAL-639
UPS1, pGAL-UPS1-GFP or pGAL-UPS1myc were grown in glucose containing 640
medium and spotted either on glucose (pPGK-UPS1) or on galactose containing 641
plates (pGAL plasmids)  with or without5-fluorouracil as indicated. Different 5FU 642
concentrations were used in order to differentiate optimally the growth of each of the 643
tested strains with regard to the various plasmids: concentration was lower in the 644
case of galactose-induced cells expressing untagged and myc-tagged AtUPS1 that 645
display greater uracil uptake activities than cells expressing GFP-tagged AtUPS1, or 646
untagged AtUPS1 under the control of the PGK promoter.  In all cases, growth was 647
tested using a whole range of 5FU concentrations, and a selection of representative 648
plates is shown.649
B: fur4 (triangle), rsp5C2 fur4 (square) and npi1 fur4 (diamond) transformed 650
with pGAL-UPS1-GFP or pGAL-UPS1myc were grown to mid log phase in raffinose 651
containing media and the expression of the various transporters was induced by 652
addition of galactose. Plasma membrane delivery of the transporters was assessed 653
by measuring uracil uptake activity at different time points after galactose addition. 654
C: Induction of AtUPS1myc was monitored in WT and npi1 cells by Western blot 655
analysis of aliquots withdrawn at several time points after addition of galactose. 656
Proteins were resolved by SDS polyacrylamide gel electrophoresis and analyzed by 657
immunoblotting with anti-myc antibodies for quantification of transporter expression 658
and anti-Gas1p as loading control. 659
660
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